Perospirone Hydrochloride Hydrate

盐酸哌罗匹隆

Report date: 2022/05/12 17:20:41
NME

Base Information

Drug NamePerospirone Hydrochloride Hydrate
Drug Alias Name哌罗匹隆PerospironaPerospironumLullanSM-9018
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsDopamine D2 receptor antagonists
TargetsSerotonin 2a (5-HT2a) receptorDopamine D2 receptor
Therapy Area/IndicationsSchizophreniaBipolar Disorder
Global Approved IndicationsSchizophreniaBipolar Disorder
Approved Indications in ChinaSchizophrenia
Original Approved Country/TerritoryJapan
Original Approved Date2000/12/22
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSumitomo Dainippon
China Registration ClassN/A

Develop Information

Active CompaniesSumitomo DainipponLivzon(Group) Pharmaceutical Factory
Inactive CompaniesN/A
Active IndicationsSchizophreniaBipolar Disorder
Inactive IndicationsN/A

Other Information

ATC CodeN05
Related LinksWikipediaDrugBankKEGG